Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1050
0.00 (0.00%)
Oct 29, 2026, 9:59 AM AEDT
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 13.49 million as of October 29, 2026. It is the 41,727th most valuable company in the world and the 1,212th biggest in Australia. Its market cap has decreased by 62.50% in one year.
Market Cap
13.49M
Enterprise Value
7.13M
Revenue
5.48M
Global Rank
Country Rank
#1,212 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 13.49M, a decrease of -29.10%. That is a compound annual growth rate of -6.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 13.49M | -64.41% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 19.43M |
| Imugene | 18.61M |
| Radiopharm Theranostics | 17.35M |
| ReNerve | 15.51M |
| Noxopharm | 15.05M |
| EZZ Life Science Holdings | 14.59M |
| Patrys | 14.56M |
| Ceryvyn Therapeutics | 13.68M |